Financials Zeo ScientifiX, Inc.

Equities

ZEOX

US68621D2062

Pharmaceuticals

Market Closed - OTC Markets 01:26:17 16/05/2024 am IST 5-day change 1st Jan Change
1.12 USD +7.69% Intraday chart for Zeo ScientifiX, Inc. 0.00% +9.80%

Valuation

Fiscal Period: October 2018 2019 2020 2021 2022 2023
Capitalization 1 5.058 15.42 143.5 68.39 40.23 12.89
Enterprise Value (EV) 1 5.395 15.94 143.4 69.11 37.52 11.83
P/E ratio -0.92 x -8.33 x -8.74 x -5.07 x -3.48 x -1.78 x
Yield - - - - - -
Capitalization / Revenue 5.24 x 9.06 x 47 x 12.2 x 6.2 x 2.83 x
EV / Revenue 5.59 x 9.37 x 46.9 x 12.3 x 5.78 x 2.59 x
EV / EBITDA -1.25 x -9.05 x -11.6 x -5.45 x -4.41 x -1.93 x
EV / FCF -4.65 x -1,228 x 54.4 x 44 x -14 x -70.6 x
FCF Yield -21.5% -0.08% 1.84% 2.27% -7.16% -1.42%
Price to Book -4.06 x -9.98 x -111 x -25.9 x 21.3 x -10.4 x
Nbr of stocks (in thousands) 2,161 2,487 4,376 5,606 7,396 7,283
Reference price 2 2.340 6.200 32.80 12.20 5.440 1.770
Announcement Date 06/03/20 16/10/20 08/02/21 14/02/22 14/02/23 29/01/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Oktober 2018 2019 2020 2021 2022 2023
Net sales 1 0.9645 1.702 3.056 5.597 6.491 4.558
EBITDA 1 -4.303 -1.762 -12.4 -12.69 -8.51 -6.138
EBIT 1 -4.311 -1.776 -12.44 -12.74 -8.843 -6.625
Operating Margin -446.97% -104.36% -407.03% -227.68% -136.23% -145.33%
Earnings before Tax (EBT) 1 -3.431 -1.738 -12.58 -12.76 -8.897 -6.987
Net income 1 -3.462 -1.737 -12.58 -12.76 -8.897 -6.987
Net margin -358.95% -102.06% -411.78% -227.9% -137.06% -153.28%
EPS 2 -2.547 -0.7441 -3.752 -2.408 -1.564 -0.9940
Free Cash Flow 1 -1.16 -0.013 2.636 1.569 -2.687 -0.1676
FCF margin -120.26% -0.76% 86.26% 28.04% -41.39% -3.68%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 06/03/20 16/10/20 08/02/21 14/02/22 14/02/23 29/01/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: October 2018 2019 2020 2021 2022 2023
Net Debt 1 0.34 0.53 - 0.72 - -
Net Cash position 1 - - 0.13 - 2.71 1.06
Leverage (Debt/EBITDA) -0.0783 x -0.2982 x - -0.0566 x - -
Free Cash Flow 1 -1.16 -0.01 2.64 1.57 -2.69 -0.17
ROE (net income / shareholders' equity) 145% 125% 852% 629% 2,290% -2,158%
ROA (Net income/ Total Assets) -1,091% -299% -784% -488% -136% -92.2%
Assets 1 0.3173 0.5815 1.605 2.616 6.546 7.579
Book Value Per Share 2 -0.5800 -0.6200 -0.3000 -0.4700 0.2600 -0.1700
Cash Flow per Share 2 0.0200 0.0500 0.1300 0.0200 0.5100 0.2400
Capex 1 0 0.03 0.14 0.5 0.82 0.03
Capex / Sales 0.47% 1.92% 4.54% 8.86% 12.71% 0.56%
Announcement Date 06/03/20 16/10/20 08/02/21 14/02/22 14/02/23 29/01/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ZEOX Stock
  4. Financials Zeo ScientifiX, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW